How consistent are cost-effectiveness estimates of a cardiovascular polypill strategy for the secondary prevention of cardiovascular disease across different cardiovascular risk equations?
17 April 2021 (08:36 - 08:45)
Organised by:
About the speaker
Barcelona (Spain)
4 More presentations in this session
Mr G. Kleinnibbelink (Nijmegen, NL)
Ms A. Abdul Razzack (Hyderabad, IN)
Access the full session
The Event
ESC Preventive Cardiology 2021
17 April 2021
08:36 CET
You may be interested in
Congress Session
